Applications of Nanotechnology in Vaccine Delivery

REFERENCES

• Rappuoli , R. , Miller , H. I. and Falkow , S. 2002 . Medicine. The intangible value of vaccination . Science , 297 : 937 – 939 .
   Google Scholar
• Klein , M. 2003 . Prospects and challenges for prophylactic and therapeutic HIV vaccines . Vaccine , 21 : 616 – 619 .
   Google Scholar
• Sally , B. , Ronald , B. M. and Eduardo , F. C. 2003 . Calculating the potential epidemic-level impact of therapeutic vaccination on the San Fransisco HIV epidemic . AIDScience , 3
   Google Scholar
• 2005 . Vaccine Introduction Guidelines: Adding a Vaccines to National Immunization Programme: Decision and Implementation www.who.int/vaccines-documents
   Google Scholar
• Plotkin , S. L. and Plotkin , S. A. 2004 . Vaccines , Philadelphia : WB Saunders Company .
   Google Scholar
• Goldsby , R. A. , Kindt , T. J. and Osborne , B. A. 2008 . Kuby Immunology , San Francisco : W. H. Freeman .
   Google Scholar
• Peek , L. J. , Middaugh , C. R. and Berkland , C. 2008 . Nanotechnology in vaccine delivery . Adv. Drug Deliv. Rev. , 60 : 915 – 928 .
   Google Scholar
• Kamath , A. T. , Feng , C. G. , Macdonald , M. , Briscoe , H. and Britton , W. J. 1999 . Differential protective efficacy of DNA vaccines expressing secreted proteins of Mycobacterium tuberculosis . Infect. Immun. , 67 : 1702 – 1707 .
   Google Scholar
• Jin , H. , Xiao , C. , Chen , Z. , Kang , Y. , Ma , Y. , Zhu , K. , Xie , Q. , Tu , Y. , Yu , Y. and Wang , B. 2005 . Induction of Th1 type response by DNA vaccinations with N, M, and E genes against SARS-CoV in mice . Biochem. Biophys. Res. Commun. , 328 : 979 – 986 .
   Google Scholar
• Burgers , W. A. , van Harmelen , J. H. , Shephard , E. , Adams , C. , Mgwebi , T. , Bourn , W. , Hanke , T. , Williamson , A. L. and Williamson , C. 2006 . Design and preclinical evaluation of a multigene human immunodeficiency virus type 1 subtype C DNA vaccine for clinical trial . J. Gen. Virol. , 87 : 399 – 410 .
   Google Scholar
• Kohli , A. K. and Alpar , H. O. 2004 . Potential use of nanoparticles for transcutaneous vaccine delivery: effect of particle size and charge . Int. J. Pharm. , 275 : 13 – 17 .
   Google Scholar
• Giudice , E. L. and Campbell , J. D. 2006 . Needle-free vaccine delivery . Adv. Drug Deliv. Rev. , 58 : 68 – 89 .
   Google Scholar
• Boyle , J. S. , Brady , J. L. and Lew , A. M. 1998 . Enhanced responses to a DNA vaccine encoding a fusion antigen that is directed to sites of immune induction . Nature , 392 : 408 – 411 .
   Google Scholar
• Lu , W. , Wu , X. , Lu , Y. , Guo , W. and Andrieu , J. M. 2003 . Therapeutic dendritic-cell vaccine for simian AIDS . Nat. Med. , 9 : 27 – 32 .
   Google Scholar
• Neundorf , I. , Rennert , R. , Franke , J. , Kozle , I. and Bergmann , R. 2008 . Detailed analysis concerning the biodistribution and metabolism of human calcitonin-derived cell-penetrating peptides . Bioconjug. Chem. , 19 : 1596 – 1603 .
   Google Scholar
• Duncan , R. 2003 . The dawning era of polymer therapeutics . Nat. Rev. Drug Discov. , 2 : 347 – 360 .
   Google Scholar
• Gursoy , R. N. and Benita , S. 2004 . Self-emulsifying drug delivery systems (SEDDS) for improved oral delivery of lipophilic drugs . Biomed. Pharmacother. , 58 : 173 – 182 .
   Google Scholar
• Putnam , D. 2006 . Polymers for gene delivery across length scales . Nat. Mater. , 5 : 439 – 451 .
   Google Scholar
• Torchilin , V. P. 2005 . Recent advances with liposomes as pharmaceutical carriers . Nat. Rev. Drug Discov. , 4 : 145 – 160 .
   Google Scholar
• Kommareddy , S. , Tiwari , S. B. and Amiji , M. M. 2005 . Long-circulating polymeric nanovectors for tumor-selective gene delivery . Technol. Cancer Res. Treat. , 4 : 615 – 625 .
   Google Scholar
• Koping-Hoggard , M. , Sanchez , A. and Alonso , M. J. 2005 . Nanoparticles as carriers for nasal vaccine delivery . Expert Rev. Vaccines , 4 : 185 – 196 .
   Google Scholar
• Tiwari , S. B. and Amiji , M. M. 2006 . A review of nanocarrier-based CNS delivery systems . Curr. Drug Deliv. , 3 : 219 – 232 .
   Google Scholar
• Borges , O. , Silva , M. , de Sousa , A. , Borchard , G. , Junginger , H. E. and Cordeiro-da-Silva , A. 2008 . Alginate coated chitosan nanoparticles are an effective subcutaneous adjuvant for hepatitis B surface antigen . Int. Immunopharmacol. , 8 : 1773 – 1780 .
   Google Scholar
• Csaba , N. , Garcia-Fuentes , M. and Alonso , M. J. 2009 . Nanoparticles for nasal vaccination . Adv. Drug Deliv. Rev. , 61 : 140 – 157 .
   Google Scholar
• Sahoo , S. K. , Parveen , S. and Panda , J. J. 2007 . The present and future of nanotechnology in human health care . Nanomedicine , 3 : 20 – 31 .
   Google Scholar
• Shahiwala , A. , Vyas , T. K. and Amiji , M. M. 2007 . Nanocarriers for systemic and mucosal vaccine delivery . Recent Pat. Drug Deliv. Formul. , 1 : 1 – 9 .
   Google Scholar
• Griffiths , G. D. , Bailey , S. C. , Hambrook , J. L. , Keyte , M. , Jayasekera , P. , Miles , J. and Williamson , E. 1997 . Liposomally-encapsulated ricin toxoid vaccine delivered intratracheally elicits a good immune response and protects against a lethal pulmonary dose of ricin toxin . Vaccine , 15 : 1933 – 1939 .
   Google Scholar
• Banchereau , J. and Steinman , R. M. 1998 . Dendritic cells and the control of immunity . Nature , 392 : 245 – 252 .
   Google Scholar
• Gamvrellis , A. , Leong , D. , Hanley , J. C. , Xiang , S. D. , Mottram , P. and Plebanski , M. 2004 . Vaccines that facilitate antigen entry into dendritic cells . Immunol. Cell. Biol. , 82 : 506 – 516 .
   Google Scholar
• Gupta , R. K. , Rost , B. E. , Relyveld , E. and Siber , G. R. 1995 . Adjuvant properties of aluminum and calcium compounds . Pharm. Biotechnol. , 6 : 229 – 248 .
   Google Scholar
• Mohanty , C. , Arya , G. , Verma , R. S. and Sahoo , S. K. 2009 . Nanobiotechnology: application of nanotechnology in therapeutics and diagnosis . Int. J. Green Nanotechnol. Biomed. , 1 : B24 – B38 .
   Google Scholar
• Nasir , A. 2009 . Nanotechnology in vaccine development: a step forward . J. Invest. Dermatol. , 129 : 1055 – 1059 .
   Google Scholar
• Abbas , A. O. , Donovan , M. D. and Salem , A. K. 2008 . Formulating poly(lactide-co-glycolide) particles for plasmid DNA delivery . J. Pharm. Sci. , 97 : 2448 – 2461 .
   Google Scholar
• Panyam , J. and Labhasetwar , V. 2003 . Biodegradable nanoparticles for drug and gene delivery to cells and tissue . Adv. Drug Deliv. Rev. , 55 : 329 – 347 .
   Google Scholar
• Illum , L. 2007 . Nanoparticulate systems for nasal delivery of drugs: a real improvement over simple systems? . J. Pharm. Sci. , 96 : 473 – 483 .
   Google Scholar
• Okada , J. , Cohen , S. and Langer , R. S. US576294 . 1998 .
   Google Scholar
• Langer , R. S. and Chen , H. US6004534 . 1999 .
   Google Scholar
• Alving , C. R. 1991 . Liposomes as carriers of antigens and adjuvants . J. Immunol. Methods , 140 : 1 – 13 .
   Google Scholar
• Alving , C. R. , Banerji , B. , Shiba , T. , Kotani , S. , Clements , J. D. and Richards , R. L. 1980 . Liposomes as vehicles for vaccines . Prog. Clin. Biol. Res. , 47 : 339 – 355 .
   Google Scholar
• Saupe , A. , McBurney , W. , Rades , T. and Hook , S. 2006 . Immunostimulatory colloidal delivery systems for cancer vaccines . Expert Opin. Drug Deliv. , 3 : 345 – 354 .
   Google Scholar
• Parr , M. J. , Ansell , S. M. , Choi , L. S. and Cullis , P. R. 1994 . Factors influencing the retention and chemical stability of poly(ethylene glycol)-lipid conjugates incorporated into large unilamellar vesicles . Biochim. Biophys. Acta , 1195 : 21 – 30 .
   Google Scholar
• van Wijk , G. M. , Gadella , T. W. , Wirtz , K. W. , Hostetler , K. Y. and van den Bosch , H. 1992 . Spontaneous and protein-mediated intermembrane transfer of the antiretroviral liponucleotide 3'-deoxythymidine diphosphate diglyceride . Biochemistry , 31 : 5912 – 5917 .
   Google Scholar
• Clark , M. A. , Blair , H. , Liang , L. , Brey , R. N. , Brayden , D. and Hirst , B. H. 2001 . Targeting polymerised liposome vaccine carriers to intestinal M cells . Vaccine , 20 : 208 – 217 .
   Google Scholar
• Nakanishi , T. , Kunisawa , J. , Hayashi , A. , Tsutsumi , Y. , Kubo , K. , Nakagawa , S. , Nakanishi , M. , Tanaka , K. and Mayumi , T. 1999 . Positively charged liposome functions as an efficient immunoadjuvant in inducing cell-mediated immune response to soluble proteins . J. Control. Release , 61 : 233 – 240 .
   Google Scholar
• de Haan , A. , Tomeea , J. F. C. , Huchshorn , J. P. and Wilschut , J. 1995 . Liposomes as an immunoadjuvant system for stimulation of mucosal and systemic antibody responses against inactivated measles virus administered intranasally to mice . Vaccine , 13 : 1320 – 1324 .
   Google Scholar
• Guan , H. H. , Budzynski , W. , Koganty , R. R. , Krantz , M. J. , Reddish , M. A. , Rogers , J. A. , Longenecker , B. M. and Samuel , J. 1998 . Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses . Bioconjug. Chem. , 9 : 451 – 458 .
   Google Scholar
• Choi , C. 2006 . New vaccine against the deadliest of all cancers teaches the body to defend itself while avoiding the side effects of more traditional therapies . Scientific American , Special Report
   Google Scholar
• Butts , C. , Murray , N. , Maksymiuk , A. , Goss , G. , Marshall , E. , Soulieres , D. , Cormier , Y. , Ellis , P. , Price , A. , Sawhney , R. , Davis , M. , Mansi , J. , Smith , C. , Vergidis , D. , Ellis , P. , MacNeil , M. and Palmer , M. 2005 . Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer . J. Clin. Oncol. , 23 : 6674 – 6681 .
   Google Scholar
• Palmer , M. , Parker , J. , Modi , S. , Butts , C. , Smylie , M. , Meikle , A. , Kehoe , M. , MacLean , G. and Longenecker , M. 2001 . Phase I study of the BLP25 (MUC1 peptide) liposomal vaccine for active specific immunotherapy in stage IIIB/IV non-small-cell lung cancer . Clin. Lung Cancer , 3 : 49 – 57 . discussion 58
   Google Scholar
• Mougin , B. , Bakouche , O. and Gerlier , D. 1988 . Humoral immune response elicited in rats by measles viral membrane antigens presented in liposomes and ISCOMs . Vaccine , 6 : 445 – 449 .
   Google Scholar
• Garnier , F. , Forquet , F. , Bertolino , P. and Gerlier , D. 1991 . Enhancement of in vivo and in vitro T cell response against measles virus haemagglutinin after its incorporation into liposomes: effect of the phospholipid composition . Vaccine , 9 : 340 – 345 .
   Google Scholar
• Kreuter , J. 1996 . Nanoparticles and microparticles for drug and vaccine delivery . J. Anat. , 189 : 503 – 505 . (Pt 3)
   Google Scholar
• Cappel , M. J. and Kreuter , J. 1991 . Effect of nanoparticles on transdermal drug delivery . J. Microencapsul. , 8 : 369 – 374 .
   Google Scholar
• Kreuter , J. 1994 . Nanoparticles in Colloidal Drug Delivery Systems , New York : Marcel Dekker .
   Google Scholar
• Bala , I. , Hariharan , S. and Kumar , M. N. 2004 . PLGA nanoparticles in drug delivery: the state of the art . Crit. Rev. Ther. Drug Carrier Syst. , 21 : 387 – 422 .
   Google Scholar
• Ueda , H. , Hariharan , S. and Kumar , M. N. 2003 . Polyhydroxy alkanonate derivative in current clinical applications and trials . Adv. Drug Deliv. Rev. , 55 : 501 – 518 .
   Google Scholar
• Fischer , S. , Uetz-von Allmen , E. , Waeckerle-Men , Y. , Groettrup , M. , Merkle , H. P. and Gander , B. 2007 . The preservation of phenotype and functionality of dendritic cells upon phagocytosis of polyelectrolyte-coated PLGA microparticles . Biomaterials , 28 : 994 – 1004 .
   Google Scholar
• Jiang , W. , Gupta , R. K. , Deshpande , M. C. and Schwendeman , S. P. 2005 . Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens . Adv. Drug Deliv. Rev. , 57 : 391 – 410 .
   Google Scholar
• Tamber , H. , Johansen , P. , Merkle , H. P. and Gander , B. 2005 . Formulation aspects of biodegradable polymeric microspheres for antigen delivery . Adv. Drug Deliv. Rev. , 57 : 357 – 376 .
   Google Scholar
• van de Weert , M. , Hennink , W. E. and Jiskoot , W. 2000 . Protein instability in poly(lactic-co-glycolic acid) microparticles . Pharm. Res. , 17 : 1159 – 1167 .
   Google Scholar
• Akagi , T. , Wang , X. , Uto , T. , Baba , M. and Akashi , M. 2007 . Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives . Biomaterials , 28 : 3427 – 3436 .
   Google Scholar
• Akashi , M. , Akagi , T. , Nakagawa , S. and Baba , M. October 10–11 2007 . Biodegradable nanoparticles for vaccine delivery and adjuvant Swiss-Japan Symposium on Nanobio October 10–11 ,
   Google Scholar
• des Rieux , A. , Fievez , V. , Garinot , M. , Schneider , Y. J. and Preat , V. 2006 . Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach . J. Control. Release , 116 : 1 – 27 .
   Google Scholar
• Jung , T. , Kamm , W. , Breitenbach , A. , Hungerer , K. D. , Hundt , E. and Kissel , T. 2001 . Tetanus toxoid loaded nanoparticles from sulfobutylated poly(vinyl alcohol)-graft-poly(lactide-co-glycolide): evaluation of antibody response after oral and nasal application in mice . Pharm. Res. , 18 : 352 – 360 .
   Google Scholar
• Avnir , D. , Braun , S. , Lev , O. and Ottolenghi , M. 1994 . Enzymes and other proteins entrapped in Sol-Gel materilas . Chem. Mater. , 6 : 1605 – 1614 .
   Google Scholar
• Jain , T. K. , Roy , I. , De , T. K. and Maitra , A. N. 1998 . Nanometer silica particles encapsulating active compounds: a novel ceramic drug carrier . J. Am. Chem. Soc. , 120 : 11092 – 11095 .
   Google Scholar
• Ochekpe , N. A. , Olorunfemi , P. O. and Ngwuluka , N. C. 2009 . Nanotechnology and drug delivery. Part 2: Nanostructures for drug delivery . Trop. J. Pharm. Res. , 3 : 275 – 287 .
   Google Scholar
• Kneuer , C. , Sameti , M. , Bakowsky , U. , Schiestel , T. , Schirra , H. , Schmidt , H. and Lehr , C. M. 2000 . A nonviral DNA delivery system based on surface modified silica-nanoparticles can efficiently transfect cells in vitro . Bioconjug. Chem. , 11 : 926 – 932 .
   Google Scholar
• Luo , D. and Saltzman , W. M. 2000 . Enhancement of transfection by physical concentration of DNA at the cell surface . Nat. Biotechnol. , 18 : 893 – 895 .
   Google Scholar
• Tischer , B. K. , Schumacher , D. , Beer , M. , Beyer , J. , Teifke , J. P. , Osterrieder , K. , Wink , K. , Zelnik , V. , Fehler , F. and Osterrieder , N. 2002 . A DNA vaccine containing an infectious Marek's disease virus genome can confer protection against tumorigenic Marek's disease in chickens . J. Gen. Virol. , 83 : 2367 – 2376 .
   Google Scholar
• Zhang , L. , Widera , G. , Bleecher , S. , Zaharoff , D. A. , Mossop , B. and Rabussay , D. 2003 . Accelerated immune response to DNA vaccines . DNA Cell. Biol. , 22 : 815 – 822 .
   Google Scholar
• Zhang , L. , Widera , G. and Rabussay , D. 2004 . Enhancement of the effectiveness of electroporation-augmented cutaneous DNA vaccination by a particulate adjuvant . Bioelectrochemistry , 63 : 369 – 373 .
   Google Scholar
• Patil , S. D. , Rhodes , D. G. and Burgess , D. J. 2005 . DNA-based therapeutics and DNA delivery systems: a comprehensive review . AAPS J. , 7 : E61 – 77 .
   Google Scholar
• Mahvi , D. M. , Shi , F. S. , Yang , N. S. , Weber , S. , Hank , J. , Albertini , M. , Schiller , J. , Schalch , H. , Larson , M. , Pharo , L. , Gan , J. , Heisey , D. , Warner , T. and Sondel , P. M. 2002 . Immunization by particle-mediated transfer of the granulocyte-macrophage colony-stimulating factor gene into autologous tumor cells in melanoma or sarcoma patients: report of a phase I/IB study . Hum. Gene Ther. , 13 : 1711 – 1721 .
   Google Scholar
• Fuller , D. H. , Loudon , P. and Schmaljohn , C. 2006 . Preclinical and clinical progress of particle-mediated DNA vaccines for infectious diseases . Methods , 40 : 86 – 97 .
   Google Scholar
• Fynan , E. F. , Webster , R. G. , Fuller , D. H. , Haynes , J. R. , Santoro , J. C. and Robinson , H. L. 1993 . DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations . Proc. Natl. Acad. Sci. U. S. A. , 90 : 11478 – 11482 .
   Google Scholar
• Luo , D. and Saltzman , W. M. 2000 . Synthetic DNA delivery systems . Nat. Biotechnol. , 18 : 33 – 37 .
   Google Scholar
• Copland , M. J. , Rades , T. , Davies , N. M. and Baird , M. A. 2005 . Lipid based particulate formulations for the delivery of antigen . Immunol. Cell. Biol. , 83 : 97 – 105 .
   Google Scholar
• Bhakta , G. , Mitra , S. and Maitra , A. 2005 . DNA encapsulated magnesium and manganous phosphate nanoparticles: potential non-viral vectors for gene delivery . Biomaterials , 26 : 2157 – 2163 .
   Google Scholar
• He , Q. , Mitchell , A. , Morcol , T. and Bell , S. J. 2002 . Calcium phosphate nanoparticles induce mucosal immunity and protection against herpes simplex virus type 2 . Clin. Diagn. Lab. Immunol. , 9 : 1021 – 1024 .
   Google Scholar
• He , Q. , Mitchell , A. R. , Johnson , S. L. , Wagner-Bartak , C. , Morcol , T. and Bell , S. J. 2000 . Calcium phosphate nanoparticle adjuvant . Clin. Diagn. Lab. Immunol. , 7 : 899 – 903 .
   Google Scholar
• Goto , N. , Kato , H. , Maeyama , J. , Eto , K. and Yoshihara , S. 1993 . Studies on the toxicities of aluminium hydroxide and calcium phosphate as immunological adjuvants for vaccines . Vaccine , 11 : 914 – 918 .
   Google Scholar
• 2007 . BioSante Pharmaceuticals , Calcium Phosphate Nanoparticles (CAP) .
   Google Scholar
• Joyappa , D. H. , Ashok Kumar , C. , Banumathi , N. , Reddy , G. R. and Suryanarayana , V. V. 2009 . Calcium phosphate nanoparticle prepared with foot and mouth disease virus P1–3CD gene construct protects mice and guinea pigs against the challenge virus . Vet. Microbiol. , 139 ( 1–2 ) : 58 – 66 .
   Google Scholar
• Boas , U. and Heegaard , P. M. 2004 . Dendrimers in drug research . Chem Soc Rev , 33 : 43 – 63 .
   Google Scholar
• Frechet , J. M. J. and Tornalia , D. 2001 . Dendrimers and Other Dentritic Polymers , New York : John Wiley & Sons .
   Google Scholar
• Ribeiro , S. , Rijpkema , S. G. , Durrani , Z. and Florence , A. T. 2007 . PLGA-dendron nanoparticles enhance immunogenicity but not lethal antibody production of a DNA vaccine against anthrax in mice . Int. J. Pharm. , 331 : 228 – 232 .
   Google Scholar
• Newkome , G. R. 2001 . Dendrimers and Dendrons: Concepts, Synthesis Applications , Weinheim : Wiley-VCH .
   Google Scholar
• Haensler , J. and Szoka , F. C. Jr. 1993 . Polyamidoamine cascade polymers mediate efficient transfection of cells in culture . Bioconjug. Chem. , 4 : 372 – 379 .
   Google Scholar
• Aulenta , F. , Hayes , W. and Rannard , S. 2003 . Dendrimers: a new class of nanoscopic containers and delivery devices . Eur. Polym. J. , 39 : 1741 – 1771 .
   Google Scholar
• Esfand , R. and Tomalia , D. A. 2001 . Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications . Drug Discov. Today , 6 : 427 – 436 .
   Google Scholar
• Svenson , S. and Tomalia , D. A. 2005 . Dendrimers in biomedical applications—reflections on the field . Adv. Drug Deliv. Rev. , 57 : 2106 – 2129 .
   Google Scholar
• Tam , J. P. 1988 . Synthetic peptide vaccine design: synthesis and properties of a high-density multiple antigenic peptide system . Proc. Natl. Acad. Sci. U. S. A. , 85 : 5409 – 5413 .
   Google Scholar
• Wang , R. , Charoenvit , Y. , Corradin , G. , Porrozzi , R. , Hunter , R. L. , Glenn , G. , Alving , C. R. , Church , P. and Hoffman , S. L. 1995 . Induction of protective polyclonal antibodies by immunization with a Plasmodium yoelii circumsporozoite protein multiple antigen peptide vaccine . J. Immunol. , 154 : 2784 – 2793 .
   Google Scholar
• Sadler , K. and Tam , J. P. 2002 . Peptide dendrimers: applications and synthesis . J. Biotechnol. , 90 : 195 – 229 .
   Google Scholar
• Moreno , C. A. , Rodrigues , R. , Oliveira , G. A. , Ferreira , V. , Nussenzweig , R. S. , Moya Castro , Z. R. , Calvo-Calle , J. M. and Nardin , E. 1999 . Preclinical evaluation of a synthetic. Plasmodium falciparum MAP malaria vaccine in Aotus monkeys and mice . Vaccine , 18 ( 1–2 ) : 89 – 99 .
   Google Scholar
• Ota , S. , Ono , T. , Morita , A. , Uenaka , A. , Harada , M. and Nakayama , E. 2002 . Cellular processing of a multibranched lysine core with tumor antigen peptides and presentation of peptide epitopes recognized by cytotoxic T lymphocytes on antigen-presenting cells . Cancer Res. , 62 : 1471 – 1476 .
   Google Scholar
• Rajanathanan , P. , Sheikh , N. A. , Attard , G. S. and Morrow , W. J. W. 1999 . Evaluation of novel aggregate structures as adjuvants; composition, toxicity studies and humoral responses . Vaccine , 17 : 715 – 730 .
   Google Scholar
• Wright , D. C. US5795582 . 1998 .
   Google Scholar
• Sheng , K. C. , Kalkanidis , M. , Pouniotis , D. S. , Esparon , S. , Tang , C. K. , Apostolopoulos , V. and Pietersz , G. A. 2008 . Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo . Eur. J. Immunol. , 38 : 424 – 436 .
   Google Scholar
• Misumi , S. , Masuyama , M. , Takamune , N. , Nakayama , D. , Mitsumata , R. , Matsumoto , H. , Urata , N. , Takahashi , Y. , Muneoka , A. , Sukamoto , T. , Fukuzaki , K. and Shoji , S. 2009 . Targeted delivery of immunogen to primate m cells with tetragalloyl lysine dendrimer . J. Immunol. , 182 : 6061 – 6070 .
   Google Scholar
• Jones , M. and Leroux , J. 1999 . Polymeric micelles—a new generation of colloidal drug carriers . Eur. J. Pharm. Biopharm. , 48 : 101 – 111 .
   Google Scholar
• Scheerlinck , J. P. and Greenwood , D. L. 2008 . Virus-sized vaccine delivery systems . Drug Discov. Today , 13 : 882 – 887 .
   Google Scholar
• Lenarczyk , A. , Le , T. T. , Drane , D. , Malliaros , J. , Pearse , M. , Hamilton , R. , Cox , J. , Luft , T. , Gardner , J. and Suhrbier , A. 2004 . ISCOM based vaccines for cancer immunotherapy . Vaccine , 22 : 963 – 974 .
   Google Scholar
• Mowat , A. M. 2005 . Dendritic cells and immune responses to orally administered antigens . Vaccine , 23 : 1797 – 1799 .
   Google Scholar
• Pearse , M. J. and Drane , D. 2005 . ISCOMATRIX adjuvant for antigen delivery . Adv. Drug Deliv. Rev. , 57 : 465 – 474 .
   Google Scholar
• Cox , J. C. , Sjolander , A. and Barr , I. G. 1998 . ISCOMs and other saponin based adjuvants . Adv. Drug Deliv. Rev. , 32 : 247 – 271 .
   Google Scholar
• Frazer , I. H. , Quinn , M. , Nicklin , J. L. , Tan , J. , Perrin , L. C. , Ng , P. , O'Connor , V. M. , White , O. , Wendt , N. , Martin , J. , Crowley , J. M. , Edwards , S. J. , McKenzie , A. W. , Mitchell , S. V. , Maher , D. W. , Pearse , M. J. and Basser , R. L. 2004 . Phase 1 study of HPV16-specific immunotherapy with E6E7 fusion protein and ISCOMATRIX adjuvant in women with cervical intraepithelial neoplasia . Vaccine , 23 : 172 – 181 .
   Google Scholar
• Davis , I. D. , Chen , W. , Jackson , H. , Parente , P. , Shackleton , M. , Hopkins , W. , Chen , Q. , Dimopoulos , N. , Luke , T. , Murphy , R. , Scott , A. M. , Maraskovsky , E. , McArthur , G. , MacGregor , D. , Sturrock , S. , Tai , T. Y. , Green , S. , Cuthbertson , A. , Maher , D. , Miloradovic , L. , Mitchell , S. V. , Ritter , G. , Jungbluth , A. A. , Chen , Y. T. , Gnjatic , S. , Hoffman , E. W. , Old , L. J. and Cebon , J. S. 2004 . Recombinant NY-ESO-1 protein with ISCOMATRIX adjuvant induces broad integrated antibody and CD4(+) and CD8(+) T cell responses in humans . Proc. Natl. Acad. Sci. U. S. A. , 101 : 10697 – 10702 .
   Google Scholar
• Rimmelzwaan , G. F. , Baars , M. , van Amerongen , G. , van Beek , R. and Osterhaus , A. D. 2001 . A single dose of an ISCOM influenza vaccine induces long-lasting protective immunity against homologous challenge infection but fails to protect Cynomolgus macaques against distant drift variants of influenza A (H3N2) viruses . Vaccine , 20 : 158 – 163 .
   Google Scholar
• Hu , K. F. , Lovgren-Bengtsson , K. and Morein , B. 2001 . Immunostimulating complexes (ISCOMs) for nasal vaccination . Adv. Drug Deliv. Rev. , 51 : 149 – 159 .
   Google Scholar
• Coulter , A. , Harris , R. , Davis , R. , Drane , D. , Cox , J. , Ryan , D. , Sutton , P. , Rockman , S. and Pearse , M. 2003 . Intranasal vaccination with ISCOMATRIX adjuvanted influenza vaccine . Vaccine , 21 : 946 – 949 .
   Google Scholar
• Thapar , M. A. , Parr , E. L. , Bozzola , J. J. and Parr , M. B. 1991 . Secretory immune responses in the mouse vagina after parenteral or intravaginal immunization with an immunostimulating complex (ISCOM) . Vaccine , 9 : 129 – 133 .
   Google Scholar
• Pinitkiatisakul , S. , Friedman , M. , Wikman , M. , Mattsson , J. G. , Lovgren-Bengtsson , K. , Stahl , S. and Lunden , A. 2007 . Immunogenicity and protective effect against murine cerebral neosporosis of recombinant NcSRS2 in different iscom formulations . Vaccine , 25 : 3658 – 3668 .
   Google Scholar
• Coombes , A. G. , Lavelle , E. C. , Jenkins , P. G. and Davis , S. S. 1996 . Single dose, polymeric, microparticle-based vaccines: the influence of formulation conditions on the magnitude and duration of the immune response to a protein antigen . Vaccine , 14 : 1429 – 1438 .
   Google Scholar
• McDermott , M. R. , Heritage , P. L. , Bartzoka , V. and Brook , M. A. 1998 . Polymer-grafted starch microparticles for oral and nasal immunization . Immunol. Cell. Biol. , 76 : 256 – 262 .
   Google Scholar
• Alpar , H. O. , Ward , K. R. and Williamson , E. D. 2000 . New strategies in vaccine delivery . S. T. P. Pharma Sci. , 10 : 269 – 278 .
   Google Scholar
• Barackman , J. D. , Singh , M. , Ugozolli , M. S. O. G. and O'Hagan , D. T. 1998 . Oral immunization with poly(lactide-co-glycolide) microparticles containing an entrapped recombinant glycoprotein (gD2) from Herpes simplex type 2 virus . S. T. P. Pharma Sci. , 8 : 41 – 46 .
   Google Scholar
• van der Lubben , I. M. , Kersten , G. , Fretz , M. M. , Beuvery , C. , Verhoefa , J. C. and Junginger , H. E. 2002 . Chitosan microparticles for mucosal vaccination against diphtheria: oral and nasal efficacy studies in mice . Vaccine , 21 : 1400 – 1408 .
   Google Scholar
• Eldridge , C. H. , Hammond , C. J. , Meulbroek , J. A. , Staas , J. K. , Gilley , R. M. and Rice , T. R. 1990 . Controlled vaccine release in the gut associated lymphoid tissues. I. Orally administered biodegradable microspheres target the Peyer's patches . J. Control. Release , 11 : 205 – 214 .
   Google Scholar
• Eldridge , J. H. , Staas , J. K. , Meulbroek , J. A. , Tice , T. R. and Gilley , R. M. 1991 . Biodegradable and biocompatible poly(dl-lactide-co-glycolide) microspheres as an adjuvant for staphylococcal enterotoxin B toxoid which enhances the level of toxin-neutralizing antibodies . Infect. Immun. , 59 : 2978 – 2986 .
   Google Scholar
• Audran , R. , Peter , K. , Dannull , J. , Men , Y. , Scandella , E. , Groettrup , M. , Gander , B. and Corradin , G. 2003 . Encapsulation of peptides in biodegradable microspheres prolongs their MHC class-I presentation by dendritic cells and macrophages in vitro . Vaccine , 21 : 1250 – 1255 .
   Google Scholar
• Johansen , P. , Men , Y. , Merkle , H. P. and Gander , B. 2000 . Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination . Eur. J. Pharm. Biopharm. , 50 : 129 – 146 .
   Google Scholar
• Men , Y. , Audran , R. , Thomasin , C. , Eberl , G. , Demotz , S. , Merkle , H. P. , Gander , B. and Corradin , G. 1999 . MHC class I- and class II-restricted processing and presentation of microencapsulated antigens . Vaccine , 17 : 1047 – 1056 .
   Google Scholar
• Prior , S. , Gander , B. , Blarer , N. , Merkle , H. P. , Subira , M. L. , Irache , J. M. and Gamazo , C. 2002 . In vitro phagocytosis and monocyte-macrophage activation with poly(lactide) and poly(lactide-co-glycolide) microspheres . Eur. J. Pharm. Sci. , 15 : 197 – 207 .
   Google Scholar
• Lunsford , L. , McKeever , U. , Eckstein , V. and Hedley , M. L. 2000 . Tissue distribution and persistence in mice of plasmid DNA encapsulated in a PLGA-based microsphere delivery vehicle . J. Drug Target. , 8 : 39 – 50 .
   Google Scholar
• Jilek , S. , Merkle , H. P. and Walter , E. 2004 . DNA-loaded biodegradable microparticles as vaccine delivery systems and their interaction with dendritic cells . Adv. Drug Deliv. Rev. , 57 : 377 – 390 .
   Google Scholar
• Eyles , J. E. , Spiers , I. D. , Williamson , E. D. O. and Analysis , A. H. 1998 . of local and systemic immunological responses after intratracheal, intra-nasal and intra-muscular administration of microsphere co-encapsulated Yersinia pestis sub-unit vaccines . Vaccine , 16 : 2000 – 2009 .
   Google Scholar
• Gutierro , I. , Hernandez , R. M. , Igartua , M. , Gascon , A. R. and Pedraz , J. L. 2002 . Influence of dose and immunization route on the serum IgG antibody response to BSA-loaded PLGA microspheres . Vaccine , 20 : 2181 – 2190 .
   Google Scholar
• Thomasin , C. , Corradin , G. , Men , Y. and Merkle , H. P. 1996 . Gander. Tetanus toxoid and synthetic malaria antigen containing poly(lactide)/poly(lactide-co-glycolide) microspheres: importance of polymer degradation and antigen release for immune response . J. Control. Release , 41 : 131 – 145 .
   Google Scholar
• Alonso , M. J. , Gupta , R. K. , Min , C. , Siber , G. R. and Langer , R. 1994 . Biodegradable microspheres as controlled-release tetanus toxoid delivery systems . Vaccine , 12 : 299 – 306 .
   Google Scholar
• Newman , K. D. , Samuel , J. and Kwon , G. 1998 . Ovalbumin peptide encapsulated in poly(d,l-lactic-co-glycolic acid) microspheres is capable of inducing a T helper type 1 immune response . J. Control. Release , 54 : 49 – 59 .
   Google Scholar
• Cleland , J. L. , Mac , A. , Boyd , B. , Yang , J. , Duenas , E. T. , Yeung , D. , Brooks , D. , Hsu , C. , Chu , H. , Mukku , V. and Jones , A. J. 1997 . The stability of recombinant human growth hormone in poly(lactic-co-glycolic acid) (PLGA) microspheres . Pharm. Res. , 14 : 420 – 425 .
   Google Scholar
• Merkle , H. P. , Fischer , S. , Watterndorf , U. , Csaba , N. and Gander , B. Microparticles as generic platform for vaccine delivery . GPEN Conference . The University of Kansas .
   Google Scholar
• Tamber , H. , Johansen , P. P. M. H. and Gander , B. 2004 . Formulation aspects of biodegradable polymeric microspheres for antigen delivery . Adv. Drug Deliv. Rev. , 57 : 357 – 376 .
   Google Scholar
• Hedley , M. L. , Curley , J. and Urban , R. 1998 . Microspheres containing plasmid-encoded antigens elicit cytotoxic T-cell responses . Nat. Med. , 4 : 365 – 368 .
   Google Scholar
• Jones , D. H. , Corris , S. , McDonald , S. , Clegg , J. C. and Farrar , G. H. 1997 . Poly(d-lactide-co-glycolide)-encapsulated plasmid DNA elicits systemic and mucosal antibody responses to encoded protein after oral administration . Vaccine , 15 : 814 – 817 .
   Google Scholar
• Wang , D. , Robinson , D. R. , Kwon , G. S. and Samuel , J. 1999 . Encapsulation of plasmid DNA in biodegradable poly(d,-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery . J. Control. Release , 57 : 9 – 18 .
   Google Scholar
• Singh , M. , Briones , M. , Ott , G. and O'Hagan , D. 1999 . Cationic microparticles: a potent delivery system for DNA vaccines . Med. Sci. ,
   Google Scholar
• Lavelle , E. C. , Jenkins , P. G. and Harris , J. E. 1997 . Oral immunization of rainbow trout with antigen microencapsulated in poly(DL-lactide-co-glycolide) microparticles . Vaccine , 15 : 1070 – 1078 .
   Google Scholar
• Takahata , H. , Lavelle , E. C. , Coombes , A. G. and Davis , S. S. 1998 . The distribution of protein associated with poly(DL-lactide co-glycolide) microparticles and its degradation in simulated body fluids . J. Control. Release. , 50 : 237 – 246 .
   Google Scholar
• Klipstein , F. A. , Engert , R. F. and Sherman , W. T. 1983 . Peroral immunization of rats with Escherichia coli heat-labile enterotoxin delivered by microspheres . Infect. Immun. , 39 : 1000 – 1003 .
   Google Scholar
• Morishita , I. , Morishita , M. , Takayama , K. , Machida , Y. and Nagai , T. 1993 . Enteral insulin delivery by microspheres in 3 different formulations using Eudragit L100 and S100 . Int. J. Pharm. , 91 : 29 – 37 .
   Google Scholar
• Lin , S. Y. , Tzan , Y. L. , Lee , C. J. and Weng , C. N. 1991 . Preparation of enteric coated microspheres of Mycoplasma hyopneumoniae vaccine with cellulose acetate phthalate: I. Formation condition and micromeritic properties . J. Microencapsul. , 8 : 317 – 325 .
   Google Scholar
• Maharaj , I. , Nairn , J. G. and Campbell , J. B. 1984 . Simple rapid method for the preparation of enteric-coated microspheres . J. Pharm. Sci. , 73 : 39 – 42 .
   Google Scholar
• Guzman , M. , Molpeceres , J. , Garcia , F. and Aberturas , M. R. 1996 . Preparation, characterization and in vitro drug release of poly-epsilon-caprolactone and hydroxypropyl methylcellulose phthalate ketoprofen loaded microspheres . J. Microencapsul. , 13 : 25 – 39 .
   Google Scholar
• Delgado , A. , Lavelle , E. C. , Hartshorne , M. and Davis , S. S. 1999 . PLG microparticles stabilised using enteric coating polymers as oral vaccine delivery systems . Vaccine , 17 : 2927 – 2938 .
   Google Scholar
• Borm , P. J. and Kreyling , W. 2004 . Toxicological hazards of inhaled nanoparticles–potential implications for drug delivery . J. Nanosci. Nanotechnol. , 4 : 521 – 531 .
   Google Scholar